hydroxyproline has been researched along with Albuminuria in 5 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxyproline excretion was increased in both types of diabetes: Type 1: 21 (10-36) (median (IQR) mumol mmol creatinine-1; Type 2: 25 (13-43) mumol mmol creatinine-1; control: 10 (6-22) mumol mmol creatinine-1 (p < 0." | 5.29 | Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria. ( Marshall, SM; Selby, PL; Shearing, PA, 1995) |
| "Aldose reductase inhibitors, and particularly sorbinil, have been reported to prevent glomerular basement membrane thickening (GBMT) and albuminuria development in diabetic rats, but contradictory observations have been published." | 3.69 | Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies. ( Andre, J; Bellon, G; Claperon, N; Feldmann, G; Guillot, R; Kassab, JP; Peyroux, J; Sternberg, M, 1994) |
| "We examined 60 IDDM patients (30 women without menstruation disturbances; 30 men; age 25-36 years old)." | 1.30 | [Microalbuminuria as a risk factor for diabetic osteopathy in patients with IDDM and renal sufficiency]. ( Goliat, E; Lipińska, A; Marusza, W; Ostrowski, K, 1998) |
| "Hydroxyproline excretion was increased in both types of diabetes: Type 1: 21 (10-36) (median (IQR) mumol mmol creatinine-1; Type 2: 25 (13-43) mumol mmol creatinine-1; control: 10 (6-22) mumol mmol creatinine-1 (p < 0." | 1.29 | Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria. ( Marshall, SM; Selby, PL; Shearing, PA, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selby, PL | 1 |
| Shearing, PA | 1 |
| Marshall, SM | 1 |
| Kassab, JP | 1 |
| Guillot, R | 1 |
| Andre, J | 1 |
| Claperon, N | 1 |
| Bellon, G | 1 |
| Feldmann, G | 1 |
| Peyroux, J | 1 |
| Sternberg, M | 1 |
| Olmos, JM | 1 |
| García, MT | 1 |
| Amado, JA | 1 |
| González-Macías, J | 1 |
| Goliat, E | 1 |
| Marusza, W | 1 |
| Ostrowski, K | 1 |
| Lipińska, A | 1 |
| Herting, W | 1 |
| Liebegott, G | 1 |
5 other studies available for hydroxyproline and Albuminuria
| Article | Year |
|---|---|
Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria.
Topics: Adult; Aged; Albuminuria; Biomarkers; Bone Resorption; Diabetes Mellitus, Type 1; Diabetes Mellitus, | 1995 |
Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies.
Topics: Albuminuria; Aldehyde Reductase; Animals; Capillaries; Collagen; Diabetes Mellitus, Experimental; Hy | 1994 |
Urine hydroxyproline increase in patients with diabetes mellitus.
Topics: Acid Phosphatase; Albuminuria; Alkaline Phosphatase; Biomarkers; Bone Resorption; Diabetes Mellitus, | 1996 |
[Microalbuminuria as a risk factor for diabetic osteopathy in patients with IDDM and renal sufficiency].
Topics: Absorptiometry, Photon; Adult; Albuminuria; Alkaline Phosphatase; Bone Density; Bone Diseases, Metab | 1998 |
[Congenital familial osteopetrosis (marble bone disease Albers-Schönberg). A contribution to the pathogenesis].
Topics: Albuminuria; Amino Acids; Anemia; Autopsy; Bone and Bones; Female; Goiter; Humans; Hydroxyproline; H | 1971 |